Expand Document  |  Expand Chapter  |  Full TOC  |  Printable HTML version
The TRIPs Agreement and Pharmaceuticals
(2000; 91 pages) View the PDF document
Table of Contents
View the documentACKNOWLEDGEMENTS
View the documentLIST OF ABBREVIATIONS AND ACRONYMS
View the documentEXECUTIVE SUMMARY
View the documentI. INTRODUCTION
Open this folder and view contentsII. GENERAL ISSUES
Open this folder and view contentsIII. TECHNICAL ISSUES
Open this folder and view contentsIV. SPECIAL ISSUES
View the documentV. ISSUES DISCUSSED IN WORKING GROUPS
View the documentVI. RECOMMENDATIONS
Open this folder and view contentsANNEXES
 

ACKNOWLEDGEMENTS

The following persons made suggestions and provided comments on earlier drafts of this report or on parts thereof; their assistance is gratefully acknowledged:

Budiono Santoso (WHO, Manila), German Velasquez (WHO, Geneva), Kin Shein (WHO, New Delhi), Linda Sitanggang (MOH, Indonesia), Lucky Slamet (MOH, Indonesia), Matthew Kennedy (WTO, Geneva), Mawarwati Djamaluddin (MOH, Indonesia), and staff of the ASEAN Secretariat.

Thanks are due to Ana Pujianti, who provided secretarial support and assisted with the layout of this report.

Special thanks are due to Carlos Correa (University of Buenos Aires, Argentina), who kindly reviewed the final draft.

The ASEAN Workshop on the TRIPs Agreement and its Impact on Pharmaceuticals was organized by the Directorate General of Drug and Food Control, Ministry of Health, Indonesia, with financial and technical support from the World Health Organization and financial support from the Rockefeller Foundation.

 

to previous section
to next section
 
 
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: March 20, 2014